关于SEBMC  
SEBMC章程  
SEBMC活动  
执行理事会
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Barbara VAN WISSEN-BOSCHET
Servier(Beijing)
Bradley Marchant, MD FRCP
Sanofi-Aventis, China
Richard Wang.Ph.D
Chief Operation Officer, Cellular Biomedicine Group and GM, Stem Cell Therapy BU
Nick Zhang
China General Manager and Corporate Sr. VP of Frontage Lab, Inc.
ZHOU ZEQI, PH.D
Vice President of Tianjin International Joint Academy of Biotechnology and Medicine
Dr. Hanmei Xu
China Pharmaceutical University
Dr Ming-Qiang Zhang
General Manager of Amgen Biopharmaceutical Research and Development (Shanghai) Company Ltd.
Dr. Mingde Xia
Senior Director in the Corporate Office of Science and Technology (COSAT) at Johnson and Johnson
Jingwu Zang
CSO of Simcere pharmaceuticals
He Sun
Tasly Holding Group Co. Ltd
Dr. Bin Wang
Professor at Fudan University Shanghai
Changqing Su
Second Military Medical University
陈春麟
美迪西生物医药董事长/中欧生物医药委员会执行理事
Chris Lu, PhD
Head of Biologics of China Novartis Institutes for Biomedical Research
曹国庆
江苏恒瑞医药集团生物研发副总经理
Li Zhu
VP Strategy of GenScript
Shawn S. Zhang, Ph.D.
NORTH CHINA PHARMACEUTICAL GROUP
Mr. Fu Jiemin
General Manager of the Shanghai Fosun Pharmaceutical (Group) CO., LTD
周新华博士
嘉和生物药业有限公司首席执行官/中欧生物医药委员会副主席
Dr. Dan Zhang
Fountain Medical Development Limited CEO
Le Sun Ph.D
President /CEO, Adjunct Prof of VacDiagn Biotechnology Co
BaoPing Wang Ph.D
GM of Novo Nordisk China R andD Center/Executive director SEBMC